Ekso Bionics (EKSO) Misses Q1 EPS by 4c

Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $3.38 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Evercore ISI Upgrades The Macerich Company (MAC) to Outperform, 'improving balance sheet and accelerating FFO growth'
• JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
• Bechtle AG (BC8:GR) (BECTY) PT Raised to EUR49 at Deutsche Bank